Mice addicted to methamphetamine who received a single injection of an experimental drug called blebbistatin did not experience a relapse, a new study finds. The drug disrupts memories of addiction, without impacting other memories, according to The Washington Post.
Researchers from The Scripps Research Institute in Jupiter, Florida say if the drug is found effective in humans, it could have a big impact on drug treatment. They hope to start human trials of blebbistatin in five years, the article notes.
“The idea is that someone would go into a rehab program with the typical abstinence therapies and while they are in the treatment program they would receive this medication one time and it should remove all of the associations with the drug,” said researcher Courtney A. Miller.
Full story of blebbistatin and methamphetamine addiction at drugfree.org